FDA.reportPublic FDA data

Application 020229

Type
NDA
Sponsor
JANSSEN PHARMS

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001LEUSTATINCLADRIBINEINJECTABLE;INJECTION1MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**YesNo

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
48231SUPPL2012-08-03
48230SUPPL2012-08-03
48232SUPPL2006-07-03
48235SUPPL2002-08-22
48234SUPPL2002-08-20
48233SUPPL2002-08-20